Table I.
Baseline characteristics of 17 patients with IgA nephropathy who underwent a repeat renal biopsy.
| Patient | Gender | Age at first biopsy (years) | Interval (months) | RAS inhibitors | Immunosuppressive treament |
|---|---|---|---|---|---|
| 1 | F | 28 | 12 | Yes | PDN + TwHF + AZA |
| 2 | M | 21 | 50.5 | Yes | PDN + TwHF +AZA |
| 3 | M | 18 | 9 | Yes | PDN + TwHF + CTX → AZA |
| 4 | M | 19 | 15 | Yes | PDN + TwHF + AZA |
| 5 | M | 14 | 15 | Yes | PDN + TwHF + AZA |
| 6 | F | 59 | 21 | Yes | PDN + TwHF |
| 7 | M | 22 | 17.5 | Yes | PDN + TwHF + AZA |
| 8 | M | 61 | 12.5 | Yes | PDN + TwHF + AZA |
| 9 | F | 31 | 14 | Yes | PDN + TwHF + AZA |
| 10 | F | 39 | 14 | Yes | PDN + TwHF + AZA |
| 11 | M | 26 | 12.5 | Yes | PDN + TwHF + AZA |
| 12 | M | 35 | 15 | Yes | PDN |
| 13 | M | 14 | 11 | Yes | PDN + AZA |
| 14 | F | 32 | 16.6 | Yes | PDN + TwHF + CTX → AZA |
| 15 | M | 26 | 17 | Yes | PDN + TwHF + AZA |
| 16 | M | 55 | 12 | Yes | PDN + AZA |
| 17 | F | 18 | 11.5 | Yes | PDN + TwHF |
IgA, immunoglobulin A; RAS, renin-angiotensin system; PDN, prednisone; TwHF, Tripterygium wilfordii Hook F; AZA, azathioprine; and CTX, cyclophosphamide.